Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy

BACKGROUND: The prognostic utility of systemic inflammatory markers has so far not been investigated in patients with metastatic testicular germ cell tumours (GCTs). METHODS: International Germ Cell Cancer Cooperative Group (IGCCCG) risk groups and blood-based systemic inflammatory markers (haemoglo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Cancer
Egile Nagusiak: Fankhauser, Christian Daniel, Sander, Sophia, Roth, Lisa, Gross, Oliver, Eberli, Daniel, Sulser, Tullio, Seifert, Burkhardt, Beyer, Joerg, Hermanns, Thomas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2018
Gaiak:
Translational Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5877429/
https://ncbi.nlm.nih.gov/pubmed/29485982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.467
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak